Vicki L. Sato - 23 May 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 23 May 2022
Net transactions value: -$80,369
Form type: 4
Filing time: 25 May 2022, 18:07:13 UTC
Previous filing: 10 May 2022
Next filing: 06 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$0	+6,405	+0.43%	$0.000000	1,509,868	23 May 2022	Direct
transaction	VIR	Common Stock	Sale	$80,369	-3,374	-0.22%	$23.82	1,506,494	24 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Award	$0	+12,810		$0.000000	12,810	23 May 2022	Common Stock	12,810	$24.14	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022.